SkinCeuticals
SkinCeuticals Retinol 0.5
SkinCeuticals Retinol 0.5
无法加载取货服务可用情况
Product Overview
SkinCeuticals Retinol 0.5 is formulated with 0.5% pure retinol — a cosmetically available vitamin A derivative that delivers clinically meaningful anti-ageing and skin-clarifying effects through its intracellular conversion to retinoic acid. Unlike retinol esters (retinyl palmitate, retinyl acetate), which require multiple enzymatic steps before reaching bioactive retinoic acid, pure retinol requires only two oxidative steps and is therefore substantially more potent on a weight-for-weight basis. The 0.5% concentration is the established starting point for retinoid-naïve patients in published dermatology protocols, providing sufficient receptor activation for meaningful clinical outcomes while minimising the erythema, scaling, and photosensitivity associated with higher concentrations or prescription-strength retinoic acid formulations.
The delivery vehicle employs a dimethicone-silicone emulsion with allyl methacrylates crosspolymer to provide controlled, steady-state release of retinol across the nocturnal application period. The soothing complex — bisabolol derived from Matricaria chamomilla and boswellia serrata gum — modulates the inflammatory cytokine response triggered by increased epidermal turnover. Dermatologists and aesthetic physicians at Singapore clinics routinely prescribe Retinol 0.5 as the foundation of a retinoid protocol, with planned escalation to Retinol 1.0 after eight to twelve weeks once tolerance is established, aligned with the American Academy of Dermatology (AAD) and Dermatological Society of Singapore (DSS) recommendations on retinoid-based skin health management.
Formulation Specifications
| Manufacturer | SkinCeuticals (L'Oréal Dermatological Beauty) |
| Product Reference | Retinol 0.5 — Refining Night Cream |
| Primary Active | 0.5% pure retinol (vitamin A alcohol) |
| Soothing Complex | Bisabolol (chamomile) + Boswellia Serrata Gum (frankincense) |
| Delivery System | Dimethicone emulsion with allyl methacrylates crosspolymer (controlled release) |
| Format | Night cream, 30 mL |
| Application | Nightly (begin alternate nights for first 4 weeks) |
| Escalation Pathway | Conditioning step before Retinol 1.0; typically 8–12 weeks before advancing |
| Fragrance / Paraben Status | Fragrance-free, paraben-free |
| Regulatory (Singapore) | Cosmetic; HSA-compliant. Distributed exclusively via authorised medical channels including EMIS Singapore. |
Clinical Indications
- Retinoid initiation in retinoid-naïve patients: Establishes baseline retinoid tolerance in patients presenting for anti-ageing, pigmentation, or acne treatment per AAD guidelines.
- Early-stage photoageing (Glogau I–II): Addresses fine lines, early solar elastosis, and mild lentigines in patients aged 25–45 at Singapore dermatology and aesthetic medicine clinics.
- Mild to moderate post-inflammatory hyperpigmentation: Accelerates pigmented corneocyte shedding in Fitzpatrick III–IV skin types common in Singapore's multi-ethnic population.
- Acne-prone skin management: Retinol normalises follicular keratinisation and reduces microcomedone formation; 0.5% is appropriate for patients with concurrent sensitivity to benzoyl peroxide.
- Conditioning before Retinol 1.0 escalation: Prepares epidermis for higher-concentration formulation over 8–12 weeks, reducing risk of severe retinisation response.
- Maintenance between professional procedures: Nightly home-care between laser, peel, or injectable sessions at Singapore aesthetic clinics to sustain procedure outcomes.
Frequently Asked Questions
Q: How long should Retinol 0.5 be used before advancing to Retinol 1.0?
A: A minimum of 8–12 weeks on Retinol 0.5 (nightly after a 4-week alternate-night introduction) before considering escalation. Markers of readiness include full nightly tolerance without significant erythema or peeling. Treating practitioners at Singapore dermatology clinics should guide escalation decisions.
Q: Can Retinol 0.5 be used during pregnancy or breastfeeding?
A: Topical retinoids are not recommended during pregnancy or breastfeeding as a precautionary measure, consistent with Obstetrical Society Singapore and international dermatology body guidance. Patients who become pregnant during retinoid use should discontinue immediately and consult their obstetrician.
Q: What is the "retinisation" response, and how should it be managed?
A: Retinisation is the adaptation phase characterised by transient dryness, mild flaking, and possible erythema in the first 2–6 weeks. Management strategies include: reducing frequency, buffering with moisturiser, and ensuring daily SPF 30+. Patients should consult their practitioner if symptoms persist beyond 6 weeks.
Q: Is Retinol 0.5 appropriate for patients with sensitive skin or rosacea?
A: Patients with rosacea or highly reactive skin should initiate retinoid use under direct dermatologist supervision. A patch test on the jawline for 48 hours prior to full-face introduction is advisable for any patient with known skin reactivity.
Q: Where can SkinCeuticals Retinol 0.5 be purchased in Singapore?
A: Available exclusively through authorised SkinCeuticals medical channels including EMIS (Essential Medical International Supplies Pte Ltd). Ensures product provenance, correct storage, and access to professional guidance on protocol design.
分享
